Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis.

about

Biocompatibility of Bespoke 3D-Printed Titanium Alloy Plates for Treating Acetabular Fractures.

P2860

Q53690555-ECBB9387-E825-4000-8FFE-8372BF3E65B4

P2860

Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis.

Item

http://www.wikidata.org/entity/Q53115717

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis.

@en

Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis.

@nl

type

Item

label

Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis.

@en

Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis.

@nl

prefLabel

Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis.

@en

Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis.

@nl

P1476

Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis.

@en

P2093

Henry Guo

http://www.w3.org/2001/XMLSchema#string

Paul O Zamora

http://www.w3.org/2001/XMLSchema#string

Xinhua Lin

http://www.w3.org/2001/XMLSchema#string

Yi Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting selectins and selectin ligands in inflammation and cancer

Recombinant human bone morphogenetic protein-2: adverse events reported to the Manufacturer and User Facility Device Experience database

Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype

Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine.

Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?

Exaggerated inflammatory response after use of recombinant bone morphogenetic protein in recurrent unicameral bone cysts.

Benefit-risk assessment of becaplermin in the treatment of diabetic foot ulcers.

Formation of painful seroma and edema after the use of recombinant human bone morphogenetic protein-2 in posterolateral lumbar spine fusions.

Graft options in posterolateral and posterior interbody lumbar fusion.

Inflammatory bone loss: pathogenesis and therapeutic intervention.

P304

154-161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1091581813476960

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23422080

http://www.w3.org/2001/XMLSchema#string

Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis.

about

P2860

P2860

Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698